Skip to Main Content

INFORMATION FOR

    Claudio R. Alarcón, PhD

    Associate Professor in Pharmacology
    DownloadHi-Res Photo

    About

    Titles

    Associate Professor in Pharmacology

    Biography

    Our lab uses multidisciplinary approaches to understand the impact of RNA metabolism in development, health and disease. We are primarily focused in identifying the physiological and pathophysiological roles of RNA modifications and non-coding RNAs at the molecular, cellular and organismal levels. Claudio, a native of Chile, obtained his Ph.D. from Cornell University in NYC. He was a postdoctoral fellow at the Rockefeller University before joining Yale University in 2017.

    Appointments

    Other Departments & Organizations

    Education & Training

    Postdoctoral Fellow
    The Rockefeller University (2017)
    PhD
    Cornell University/Sloan Kettering Institute (2009)
    BSc
    P. Universidad Católica de Chile, Biochemistry (1999)

    Research

    Overview

    Using bioinformatics, molecular and cellular approaches to analyze groups of genes that were altered in highly metastatic compared to poorly metastatic parental populations of breast cancer cells, we identified three miRNAs to be downregulated in breast and bone metastasis (Tavazoie et al., 2008). Furthermore, we identified the transcription factor SOX4 as a miR335 target gene that promotes breast cancer metastasis. We have recently systematically and unbiasedly identified TMEM2 as a downstream target and mediator of SOX4’s effects on breast cancer metastatic cell invasion. Both SOX4 and TMEM2 associates with clinical cancer progression (Lee et al., 2016). Additionally, trying to understand global mechanisms of miRNA processing that could be disrupted in cancer, we discovered that the RNA modification m6A facilitates primary miRNA recognition and miRNA biogenesis and identified HNRNPA2B1 as a nuclear bridge between m6A modified RNA and the miRNA processing machinery. These experiments allowed the discovery of the microRNA biogenesis as an unexpected molecular process regulated by m6A. We are now focused on understanding the impact of m6A RNA modification in cancer initiation and progression.

    Medical Research Interests

    Neoplasm Metastasis

    Get In Touch